Training in Adolescent Substance and Opioid Misuse in Pediatric Residency Programs Free

We developed an online survey on substance use education that was approved and distributed by the Association of Pediatric Program Directors. The 25-item survey assessed program leadership’s estimated content on substance use and the perceived quality of that training. The survey was distributed by e-mail to pediatric associate program directors from all 201 US pediatric residency programs in March 2019. Associate program directors were surveyed per recommendation by the Association of Pediatric Program Directors and were given the option of forwarding the survey to a faculty member with more knowledge about the curriculum. Results presented in this article are a subset of questions from the survey; the full survey and results are available online (https://hdl.handle.net/2144/41197).

Opioid overdose mortality for each program’s county was obtained from the Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research.⁶  Counties were classified as having “high” or “low” mortality relative to the national 2018 age-adjusted mean of 14.6 per 100 000.⁷ 

Descriptive statistics were used to summarize results, with χ² analyses to evaluate associations between training and location within high versus low overdose counties. The study was considered exempt by the Boston University Medical Campus Institutional Review Board.

Surveys were completed by 120 of 201 programs (60%; Table 1). Ninety-seven programs had county-level overdose data and were included in final analyses. Most programs offered some education on adolescent substance use (n = 80, 82.5%); 77 programs required it and 61 programs offered elective opportunities. Fewer than half provided training inclusive of AAP-recommended SBIRT (n = 40, 41.2%; Table 2).

Programs in high-overdose counties were more likely to have education on opioids (including about substance-exposed neonates) as a part of their standard residency curriculum than those in low-overdose counties (79.7% vs 52.6%, P = .005; Table 2). Few programs offered a buprenorphine waiver course (n = 22, 22.5%), although programs in high-overdose counties were more likely to have any residents complete this optional training (22.0% vs 5.3%, P = .03).

Overall, 97.5% of programs reported that training about opioid misuse was “important” or “very important,” although just 12.5% rated their overall education on opioid misuse as “good” or “very good.” The main barriers to providing education about adolescent opioid misuse included insufficient faculty expertise (62.8%), curricular time (50.4%), and available content (47.9%). Only 3.3% of programs identified lack of interest as a barrier. All (100%) respondents reported interest in a shared, web-based curriculum on adolescent opioid misuse and related topics.

Although most US pediatric residency programs provide education about adolescent substance use, gaps remain, particularly with respect to opioid misuse. Programs in counties with a high opioid overdose burden had more training on OUD, but overall rates of training inclusive of treatment were low. Two AAP-recommended interventions, SBIRT and medications for OUD, were infrequently covered.^4,5  Few programs offer education about how to prescribe naloxone, a life-saving intervention for opioid overdose, despite high regional overdose mortality and widespread availability of such training.

This study had limitations. The survey collected self-reported data, which may be subject to social desirability bias, and some respondents may have been unaware of the full extent of the training offered.

Given that substance use disorders often have their onset in adolescence and that opioid-related mortality among youth is rising, addressing gaps in training for pediatricians should be a priority.

AAP

American Academy of Pediatrics

OUD

opioid use disorder

SBIRT

screening, brief intervention, referral to treatment